Related Experiment Video
Updated: May 23, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
MED28 regulates MEK1-dependent cellular migration in human breast cancer cells
Chun-Yin Huang1, Yu-Hsuan Chou, Nien-Tsu Hsieh
1Department of Nutrition, China Medical University, Taichung, Taiwan, ROC.
Abstract:
MED28, a mammalian Mediator subunit, exhibits several cellular roles, including a merlin, Grb2, and cytoskeleton-associated protein (magicin), a repressor of smooth muscle cell differentiation, and an endothelial-derived gene (EG-1). Overexpression of MED28 may stimulate cell proliferation which presumably results from the transcriptional activation of the Mediator function. Additionally, several tumors, including breast cancer, highly express MED28. We have found recently that MED28 potentiated epidermal growth factor (EGF)-induced migration in human breast cancer cells. Therefore, the objective of this study is to identify the role of MED28 in the aspect of cellular migration and invasion in human breast cancer cells. Suppression of MED28 blocked cellular migration and invasion with concomitant reduced expression levels of matrix metalloproteinase-2 (MMP2) and mitogen-activated protein kinase kinase 1 (MAP2K1; MEK1); overexpression of MED28 enhanced cellular migration and upregulated MMP2 and MEK1 expression. Moreover, suppression of MEK1, by dominant-negative, kinase-dead MEK1 cDNA construct or MEK1-specific small interfering RNA (siRNA) as well as MEK1 inhibitors, blocked MED28-induced MMP2 activation, cellular migration, and invasion in breast cancer cells. Furthermore, ectopic expression of MEK1 rescued the inhibitory effect of MED28 knockdown on invasion, and exogenous MMP2 recombinant protein recovered the suppression on invasion upon MED28 or MEK1 knockdown. Our data indicate that MED28 regulates cellular migration in a MEK1-dependent manner in human breast cancer cells, reinforcing the important cellular roles of MED28.
Insights
MED28 protein promotes human breast cancer cell migration and invasion by upregulating MEK1 and MMP2. Suppressing MED28 inhibits these processes, highlighting MED28 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- MED28 is a mammalian Mediator subunit implicated in various cellular functions.
- MED28 is overexpressed in several cancers, including breast cancer.
- MED28 has been shown to potentiate epidermal growth factor (EGF)-induced migration.
Purpose of the Study:
- To investigate the role of MED28 in cellular migration and invasion in human breast cancer cells.
- To elucidate the molecular mechanisms by which MED28 influences cancer cell motility.
Main Methods:
- MED28 knockdown and overexpression in human breast cancer cells.
- Assessment of cellular migration and invasion assays.
- Analysis of matrix metalloproteinase-2 (MMP2) and mitogen-activated protein kinase kinase 1 (MAP2K1; MEK1) expression levels.
- Functional studies using dominant-negative MEK1 constructs, MEK1-specific siRNA, MEK1 inhibitors, and recombinant MMP2.
Main Results:
- MED28 suppression inhibited cell migration and invasion, reducing MMP2 and MEK1 expression.
- MED28 overexpression enhanced cell migration and upregulated MMP2 and MEK1.
- MEK1 inhibition blocked MED28-induced MMP2 activation, migration, and invasion.
- Ectopic MEK1 expression rescued MED28 knockdown effects, and exogenous MMP2 restored invasion.
Conclusions:
- MED28 regulates human breast cancer cell migration and invasion.
- The MEK1/MAPK pathway is essential for MED28-mediated cellular motility.
- MED28 plays a significant role in promoting breast cancer progression via MEK1 and MMP2.
Related Concept Videos
Mitogens and the Cell Cycle
MAPK Signaling Cascades
Cell Migration
Cell Migration
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

